Other formats:
BibTeX
LaTeX
RIS
@proceedings{1642620,
author = {Noskova, H. and Adamcová, Soňa and Knoflíčková, Dana and Pál, Karol and Grioni, Andrea and Hornakova, T. and Merta, T. and Mudry, P. and Pavelka, Z. and Vejmelkova, K. and Sterba, J. and Slabý, Ondřej},
booktitle = {Conference on Molecular Analysis for Personalised Therapy (MAP)},
doi = {http://dx.doi.org/10.1093/annonc/mdz413.102},
keywords = {exome sequencing},
language = {eng},
title = {Comparison of whole exome sequencing and FoundationOne Heme sequencing panel as tools for precision oncology in paediatric patients with difficult-to-treat solid tumours},
year = {2019}
}
TY - CONF
ID - 1642620
AU - Noskova, H. - Adamcová, Soňa - Knoflíčková, Dana - Pál, Karol - Grioni, Andrea - Hornakova, T. - Merta, T. - Mudry, P. - Pavelka, Z. - Vejmelkova, K. - Sterba, J. - Slabý, Ondřej
PY - 2019
TI - Comparison of whole exome sequencing and FoundationOne Heme sequencing panel as tools for precision oncology in paediatric patients with difficult-to-treat solid tumours
KW - exome sequencing
N2 - The necessary condition for the application of precision oncology approach into the routine is a detailed molecular characterization of the tumour. In our study, we explored clinical applicability of both whole exome sequencing (WES) and FoundationOne Heme (F1Heme) panel (Foundation Medicine, Inc., MA, USA) as comprehensive genomic profiling tools in a cohort of 35 children with difficult-to-treat solid tumours.
ER -
NOSKOVA, H., Soňa ADAMCOVÁ, Dana KNOFLÍČKOVÁ, Karol PÁL, Andrea GRIONI, T. HORNAKOVA, T. MERTA, P. MUDRY, Z. PAVELKA, K. VEJMELKOVA, J. STERBA and Ondřej SLABÝ. Comparison of whole exome sequencing and FoundationOne Heme sequencing panel as tools for precision oncology in paediatric patients with difficult-to-treat solid tumours. In \textit{Conference on Molecular Analysis for Personalised Therapy (MAP)}. 2019. ISSN~0923-7534. Available from: https://dx.doi.org/10.1093/annonc/mdz413.102.
|
